Responses
Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
76 Potential mechanisms of resistance identified through analysis of multiple biomarkers in immune hot non-responders with non-small cell lung cancer (NSCLC) treated with tislelizumab
Compose a Response to This Article
Other responses
No responses have been published for this article.